Annual FCF
-$317.54 M
-$132.87 M-71.95%
December 31, 2023
Summary
- As of February 23, 2025, FGEN annual free cash flow is -$317.54 million, with the most recent change of -$132.87 million (-71.95%) on December 31, 2023.
- During the last 3 years, FGEN annual FCF has fallen by -$395.15 million (-509.16%).
- FGEN annual FCF is now -509.16% below its all-time high of $77.61 million, reached on December 31, 2020.
Performance
FGEN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$8.46 M
+$31.43 M+78.79%
September 30, 2024
Summary
- As of February 23, 2025, FGEN quarterly free cash flow is -$8.46 million, with the most recent change of +$31.43 million (+78.79%) on September 30, 2024.
- Over the past year, FGEN quarterly FCF has increased by +$10.11 million (+54.46%).
- FGEN quarterly FCF is now -105.68% below its all-time high of $148.94 million, reached on June 30, 2020.
Performance
FGEN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$126.23 M
+$76.76 M+37.82%
September 30, 2024
Summary
- As of February 23, 2025, FGEN TTM free cash flow is -$126.23 million, with the most recent change of +$76.76 million (+37.82%) on September 30, 2024.
- Over the past year, FGEN TTM FCF has increased by +$191.31 million (+60.25%).
- FGEN TTM FCF is now -237.13% below its all-time high of $92.05 million, reached on March 31, 2021.
Performance
FGEN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
FGEN Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -72.0% | +54.5% | +60.3% |
| 3 y3 years | -509.2% | +54.5% | +60.3% |
| 5 y5 years | -277.3% | +54.5% | +60.3% |
FGEN Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -182.5% | at low | at high | +92.4% | -12.7% | +64.1% |
| 5 y | 5-year | -509.2% | at low | -105.7% | +92.4% | -237.1% | +64.1% |
| alltime | all time | -509.2% | at low | -105.7% | +92.4% | -237.1% | +64.1% |
FibroGen Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.46 M(-78.8%) | -$126.23 M(-37.8%) |
| Jun 2024 | - | -$39.88 M(-32.8%) | -$202.99 M(-26.1%) |
| Mar 2024 | - | -$59.32 M(+219.4%) | -$274.68 M(-13.5%) |
| Dec 2023 | -$317.54 M(+71.9%) | -$18.57 M(-78.2%) | -$317.54 M(-9.7%) |
| Sep 2023 | - | -$85.22 M(-23.6%) | -$351.81 M(+10.2%) |
| Jun 2023 | - | -$111.56 M(+9.2%) | -$319.34 M(+32.1%) |
| Mar 2023 | - | -$102.18 M(+93.4%) | -$241.74 M(+30.9%) |
| Dec 2022 | -$184.67 M(+64.3%) | -$52.85 M(+0.2%) | -$184.67 M(-1.9%) |
| Sep 2022 | - | -$52.74 M(+55.3%) | -$188.18 M(+59.8%) |
| Jun 2022 | - | -$33.97 M(-24.7%) | -$117.76 M(+5.1%) |
| Mar 2022 | - | -$45.11 M(-19.9%) | -$112.03 M(-0.3%) |
| Dec 2021 | -$112.42 M(-244.9%) | -$56.36 M(-418.8%) | -$112.42 M(+71.2%) |
| Sep 2021 | - | $17.68 M(-162.6%) | -$65.68 M(-22.8%) |
| Jun 2021 | - | -$28.24 M(-37.9%) | -$85.13 M(-192.5%) |
| Mar 2021 | - | -$45.50 M(+373.1%) | $92.05 M(+18.6%) |
| Dec 2020 | $77.61 M(-191.9%) | -$9.62 M(+444.0%) | $77.61 M(+92.0%) |
| Sep 2020 | - | -$1.77 M(-101.2%) | $40.43 M(+213.3%) |
| Jun 2020 | - | $148.94 M(-348.5%) | $12.90 M(-107.8%) |
| Mar 2020 | - | -$59.95 M(+28.1%) | -$166.41 M(+97.0%) |
| Dec 2019 | -$84.47 M | -$46.80 M(+59.7%) | -$84.47 M(+44.9%) |
| Sep 2019 | - | -$29.29 M(-3.6%) | -$58.30 M(+166.1%) |
| Jun 2019 | - | -$30.38 M(-238.1%) | -$21.91 M(-22.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $22.00 M(-206.6%) | -$28.37 M(-66.3%) |
| Dec 2018 | -$84.16 M(+12.2%) | -$20.63 M(-390.6%) | -$84.16 M(+23.4%) |
| Sep 2018 | - | $7.10 M(-119.3%) | -$68.22 M(-29.8%) |
| Jun 2018 | - | -$36.83 M(+9.0%) | -$97.14 M(+19.9%) |
| Mar 2018 | - | -$33.80 M(+620.1%) | -$81.04 M(+8.0%) |
| Dec 2017 | -$75.01 M(-1381.0%) | -$4.69 M(-78.5%) | -$75.01 M(-15.7%) |
| Sep 2017 | - | -$21.81 M(+5.2%) | -$89.01 M(+28.9%) |
| Jun 2017 | - | -$20.73 M(-25.3%) | -$69.05 M(+1736.9%) |
| Mar 2017 | - | -$27.77 M(+48.6%) | -$3.76 M(-164.2%) |
| Dec 2016 | $5.86 M(-128.5%) | -$18.69 M(+908.1%) | $5.86 M(-138.9%) |
| Sep 2016 | - | -$1.85 M(-104.2%) | -$15.06 M(-71.0%) |
| Jun 2016 | - | $44.56 M(-345.4%) | -$52.02 M(-1422.2%) |
| Mar 2016 | - | -$18.16 M(-54.2%) | $3.93 M(-119.1%) |
| Dec 2015 | -$20.55 M(-243.7%) | -$39.61 M(+2.1%) | -$20.55 M(+182.4%) |
| Sep 2015 | - | -$38.80 M(-138.6%) | -$7.28 M(+548.6%) |
| Jun 2015 | - | $100.51 M(-335.7%) | -$1.12 M(-89.3%) |
| Mar 2015 | - | -$42.64 M(+61.9%) | -$10.49 M(-173.4%) |
| Dec 2014 | $14.30 M(-25.2%) | -$26.34 M(-19.3%) | $14.30 M(-64.8%) |
| Sep 2014 | - | -$32.65 M(-135.8%) | $40.64 M(-44.6%) |
| Jun 2014 | - | $91.14 M(-610.5%) | $73.29 M(-510.5%) |
| Mar 2014 | - | -$17.85 M | -$17.85 M |
| Dec 2013 | $19.11 M(-401.0%) | - | - |
| Dec 2012 | -$6.35 M | - | - |
FAQ
- What is FibroGen annual free cash flow?
- What is the all time high annual FCF for FibroGen?
- What is FibroGen annual FCF year-on-year change?
- What is FibroGen quarterly free cash flow?
- What is the all time high quarterly FCF for FibroGen?
- What is FibroGen quarterly FCF year-on-year change?
- What is FibroGen TTM free cash flow?
- What is the all time high TTM FCF for FibroGen?
- What is FibroGen TTM FCF year-on-year change?
What is FibroGen annual free cash flow?
The current annual FCF of FGEN is -$317.54 M
What is the all time high annual FCF for FibroGen?
FibroGen all-time high annual free cash flow is $77.61 M
What is FibroGen annual FCF year-on-year change?
Over the past year, FGEN annual free cash flow has changed by -$132.87 M (-71.95%)
What is FibroGen quarterly free cash flow?
The current quarterly FCF of FGEN is -$8.46 M
What is the all time high quarterly FCF for FibroGen?
FibroGen all-time high quarterly free cash flow is $148.94 M
What is FibroGen quarterly FCF year-on-year change?
Over the past year, FGEN quarterly free cash flow has changed by +$10.11 M (+54.46%)
What is FibroGen TTM free cash flow?
The current TTM FCF of FGEN is -$126.23 M
What is the all time high TTM FCF for FibroGen?
FibroGen all-time high TTM free cash flow is $92.05 M
What is FibroGen TTM FCF year-on-year change?
Over the past year, FGEN TTM free cash flow has changed by +$191.31 M (+60.25%)